TNF and psoriasis: Although anti-psoriasis biologic agents inhibiting TNF-a, IL-23/IL-12, IL-17A, and IL-17 receptors have achieved great therapeutic effectiveness compared to traditional treatments, the therapeutic effects are varied between patients and the skin lesions often recur once the biologics will be withdrawn (61).